The Cooper Companies Inc (COO) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Jul 31 2026 to Jul 31 2025 - CSIMarket
CSIMarket
 


The Cooper Companies Inc   (NASDAQ: COO)


The Cooper Companies Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is The Cooper Companies Inc's ROI in the third quarter of 2026?
The Cooper Companies Inc achieved a return on average invested assets (ROI) of 5.13 % in its third quarter of 2026, which is below The Cooper Companies Inc's average return on investment, which stands at 8.1%.

ROI has improved compared to 2.09% in the second quarter of 2026, due to net income growth.

Within the Healthcare sector 133 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 1701 to 2110.

Definition and Formula of Return on Investment



Return On Investment (Jul 31 2026)
III. Quarter
(Apr 30 2026)
II. Quarter
(Jan 31 2026)
I. Quarter
(Oct 31 2025)
IV. Quarter
(Jul 31 2025)
III. Quarter
Y / Y Investment Change TTM -2.58 % -0.3 % 2.28 % 3.41 % 4.1 %
Y / Y Net Income Change TTM 39.85 % -43.07 % 22.94 % 68.72 % 289.49 %
Investment (TTM) in Millions 10,807 10,806 11,410 11,410 11,493
Return On Investment (TTM) 5.13 % 2.09 % 3.5 % 3.28 % 3.58 %
COO's Overall Ranking # 2110 # 1701 # 1235 # 1520 # 1398
Seq. Investment Change TTM -1.52 % -1.58 % 0.26 % 0.26 % 0.78 %
Seq. Net Income Change TTM 141.86 % -41.26 % 7.07 % -8.07 % -1.55 %
Net Income (TTM) in Millions 570 236 401 375 408




Return On Investment COO's Ranking
Within: No.
Industry # 44
Sector # 134
Overall # 2110

Return On Investment Statistics
High Average Low
38.37 %
8.1 %
2.1 %
(Jul 31 2021)   (Apr 30 2026)







Financial Statements
The Cooper Companies Inc's III. Quarter Investments $ 10,807 Millions COO's Balance sheet
The Cooper Companies Inc's III. Quarter Income $ 433 Millions Quarterly COO's Income Statement
COO's Income by Division See COO's Income by Division


COO Annual Return On Investment (Oct 31 2025)
2025
(Oct 31 2024)
2024
(Oct 31 2023)
2023
(Oct 31 2022)
2022
(Oct 31 2021)
2021
Total Investments in Millions 11,282 11,293 10,690 10,212 8,874
Y / Y Investment Growth -0.09 % 5.64 % 4.68 % 15.08 % 54.79 %
Net Income in Millions 375 392 294 386 2,945
Y / Y Net Income Growth -4.44 % 33.34 % -23.74 % -86.9 % 1135.19 %
Annual Return On Investment 3.32 % 3.47 % 2.75 % 3.78 % 33.18 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 3.32 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
COO's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for COO's Competitors
Subscribers only: Roi for The Cooper Companies Inc's Suppliers
Subscribers only: Return On Investment for COO's Customers

Other Ratios
COO's Roa COO's Inventory Turnover Ratio COO's Growth Rates COO's Dividend Statistics
COO's Profitability Ratios COO's Asset Turnover Ratio COO's Dividend Growth
COO's Roe COO's Valuation Ratios COO's Financial Strength Ratios COO's Dividend Payout Ratio



Companies with similar Return On Investment at Jul 31 2026, within Healthcare Sector ROI
Alpha Pro Tech Ltd   13.80 %
Bristol myers Squibb Company  13.58 %
Transmedics Group Inc   13.46 %
Strata Critical Medical Inc   13.34 %
Johnson and Johnson  13.30 %
Amgen Inc   13.08 %
Medinotec Inc   13.06 %
Lantheus Holdings Inc   13.02 %
Msa Safety Inc  13.02 %
Universal Health Services Inc   12.43 %
Ufp Technologies Inc   12.12 %
Solventum Corporation  11.98 %
Ligand Pharmaceuticals Incorporated  11.93 %
Lifevantage Corp  11.84 %
Regeneron Pharmaceuticals Inc   11.83 %
Protagonist Therapeutics inc   11.66 %
Encompass Health Corporation  11.56 %
Embecta Corp   11.20 %
Lemaitre Vascular Inc   11.20 %
3m Company  11.16 %
Globus Medical Inc   11.01 %
National Healthcare Corp  10.91 %
Bioventus Inc   10.85 %
Infusystem Holdings Inc  10.53 %
Livanova Plc  10.40 %
Beone Medicines Ltd   10.32 %
Entrada Therapeutics Inc   10.15 %
Jazz Pharmaceuticals Plc  10.06 %
Prestige Consumer Healthcare Inc   10.06 %
Tactile Systems Technology Inc   10.02 %


Date modified: 2026-09-11T09:38:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.